Uncategorized
Aerie to collaborate with GrayBug for novel delivery of ophthalmic treatments
Aerie Pharmaceuticals and GrayBug announced a partnership and licensing agreement to collaborate on delivery technologies for Aerie’s ophthalmic treatment candidates, according to an Aerie news release. The collaboration includes an exclusive option for Aerie to license GrayBug technology to develop and commercialize sustained-release versions of Aerie's ophthalmic products, according to the release.